American Portfolios Advisors’s Regenxbio RGNX Stock Holding History

American Portfolios Advisors’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$661	Hold	25	–	–	﹤0.01%	3345
2022 Q2	$618	Hold	25	–	–	﹤0.01%	3365
2022 Q1	$830	Hold	25	–	–	﹤0.01%	3405
2021 Q4	$818	Hold	25	–	–	﹤0.01%	3352
2021 Q3	$1.05K	Hold	25	–	–	﹤0.01%	3293
2021 Q2	$971	Hold	25	–	–	﹤0.01%	3267
2021 Q1	$853	Hold	25	–	–	﹤0.01%	3155
2020 Q4	$1.13K	Hold	25	–	–	﹤0.01%	2815
2020 Q3	$688	Sell	25 -50	-67%	-$1.63K	﹤0.01%	2816
2020 Q2	$2.76K	Hold	75	–	–	﹤0.01%	2439
2020 Q1	$2.43K	Sell	75 -100	-57%	-$4.17K	﹤0.01%	2330
2019 Q4	$7.17K	Hold	175	–	–	﹤0.01%	2138
2019 Q3	$6.23K	Sell	175 -30	-15%	-$1.22K	﹤0.01%	2108
2019 Q2	$10.5K	Buy	205 +110	+116%	+$5.49K	﹤0.01%	1882
2019 Q1	$5.44K	Buy	95 +45	+90%	+$2.23K	﹤0.01%	2066
2018 Q4	$2.1K	Buy	+50	New	+$2.93K	﹤0.01%	2124

Other funds holding RGNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

American Portfolios Advisors's RGNX Position: Q3 2022 in Review

American Portfolios Advisors held its Regenxbio (RGNX) position steady in Q3 2022 at 25 shares worth $661. The position accounts for ﹤0.01% of the portfolio, ranked #3345.

American Portfolios Advisors first reported a position in RGNX in Q4 2018 and has held it in 16 quarters since. The position peaked at $10.5K in Q2 2019. 183 funds tracked by Wall St. Rank hold RGNX as of Q3 2022.

American Portfolios Advisors held 25 shares of Regenxbio worth $661 as of Q3 2022.
American Portfolios Advisors left its Regenxbio share count unchanged in Q3 2022.
Regenxbio made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #3345 holding.
American Portfolios Advisors first reported a position in Regenxbio in Q4 2018 and has held it in 16 quarters since.
American Portfolios Advisors's Regenxbio position peaked at $10.5K in Q2 2019.
183 funds tracked by Wall St. Rank held Regenxbio as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.